Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada
Abstract Background: With legal access to medical cannabis in Canada since 2001, there is a need to fully characterize its…
Abstract Background: With legal access to medical cannabis in Canada since 2001, there is a need to fully characterize its…
Abstract Hemp (Cannabis sativa L.) seed is emerging as a novel source of plant protein owing to its rich protein…
Abstract Background: In developing countries like India, irrespective of the various government laws and actions, substance abuse is a growing…
Abstract Background: The use of illicit substances is a critical international issue that must be addressed by healthcare systems worldwide.…
Abstract Background: With widespread moves toward legalization of cannabis, increasing numbers of people with multiple sclerosis (pwMS) are using the…
Abstract Background: The US national surveys and data from legal adult use cannabis states show increases in the prevalence of…
Abstract Isolation of the therapeutic cannabinoid compounds from Cannabis Sativa L. (C. Sativa) is important for the development of cannabis-based…
Abstract There has been a steady increase in cannabis use among US adolescents over the past decade. Perceptions of risk,…
Abstract The identification of cannabinoid ligands Cannabidiol and O-1918 as inverse agonists of the orphan receptor GPR52 is reported. Detailed…
Abstract In light of legislative changes and the widespread use of cannabis as a recreational and medicinal drug, delayed effects…